(FM) Neurología
Departamento académico
![Foto de (FM) Neurología](/img/uploaded/917D78EB177071228AD05EA844F64872.jpg)
![Foto de Hospital Universitario Marqués de Valdecilla](/img/noimage_org.png)
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (26)
2024
-
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Frontiers in Neurology , Vol. 15
2023
-
Medical help-seeking intentions among patients with early Alzheimer’s disease
Frontiers in Psychiatry, Vol. 14
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2022
-
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1
2020
-
Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)
Psychopharmacology
-
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study
Journal of Neuro-Oncology, Vol. 148, Núm. 3, pp. 545-554
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats
Psychopharmacology, Vol. 237, Núm. 8, pp. 2419-2431
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
2018
-
Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study
Movement Disorders, Vol. 33, Núm. 11, pp. 1809-1813
-
Using Kinect to classify Parkinson's disease stages related to severity of gait impairment
BMC Bioinformatics, Vol. 19, Núm. 1
2017
-
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
Movement Disorders, Vol. 32, Núm. 7, pp. 1066-1073
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9
BMC Neurology